Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1994 Jan;37(1):93–96. doi: 10.1111/j.1365-2125.1994.tb04248.x

Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.

H Bagheri 1, P Picault 1, L Schmitt 1, G Houin 1, M Berlan 1, J L Montastruc 1
PMCID: PMC1364719  PMID: 8148228

Abstract

The pharmacokinetic parameters and the time course of the effect after acute oral administration of yohimbine on salivary secretion in patients treated with tricyclic antidepressants were investigated. Yohimbine (10 mg) increased both salivary outflow and plasma noradrenaline levels for 4 h. Pharmacokinetic parameters (t1/2, tmax, Cmax and AUCexp) and plasma concentrations of noradrenaline were higher in patients treated with tricyclic antidepressants than in controls. At this dose, yohimbine induced a relatively large number of side effects. A lower dose (4 mg) increased salivary secretion for 3 h without any side effects in patients treated with tricyclic antidepressants but not in healthy volunteers. These data describe an interaction between yohimbine and tricyclic antidepressants and thus show that a relatively low dose (4 mg) of yohimbine could be useful in the treatment of dry mouth due to tricyclic antidepressants.

Full text

PDF
93

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagheri H., Schmitt L., Berlan M., Montastruc J. L. Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants. Br J Clin Pharmacol. 1992 Dec;34(6):555–558. doi: 10.1111/j.1365-2125.1992.tb05661.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berlan M., Galitzky J., Riviere D., Foureau M., Tran M. A., Flores R., Louvet J. P., Houin G., Lafontan M. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women. Int J Obes. 1991 May;15(5):305–315. [PubMed] [Google Scholar]
  3. Berlan M., Le Verge R., Galitzky J., Le Corre P. Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine. Br J Pharmacol. 1993 Apr;108(4):927–932. doi: 10.1111/j.1476-5381.1993.tb13488.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berlan M., Montastruc J. L., Lafontan M. Pharmacological prospects for alpha 2-adrenoceptor antagonist therapy. Trends Pharmacol Sci. 1992 Jul;13(7):277–282. doi: 10.1016/0165-6147(92)90085-k. [DOI] [PubMed] [Google Scholar]
  5. Blackwell B., Stefopoulos A., Enders P., Kuzma R., Adolphe A. Anticholinergic activity of two tricyclic antidepressants. Am J Psychiatry. 1978 Jun;135(6):722–724. doi: 10.1176/ajp.135.6.722. [DOI] [PubMed] [Google Scholar]
  6. Chatelut E., Rispail Y., Berlan M., Montastruc J. L. Yohimbine increases human salivary secretion. Br J Clin Pharmacol. 1989 Sep;28(3):366–368. doi: 10.1111/j.1365-2125.1989.tb05440.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chiba R., Isii Y. [Determination of yohimbine in serum by high performance liquid chromatography]. Yakugaku Zasshi. 1990 Apr;110(4):289–292. doi: 10.1248/yakushi1947.110.4_289. [DOI] [PubMed] [Google Scholar]
  8. Girolami J. P., Bascands J. L., Pécher C., Berlan M., Montastruc J. L., Montastruc P. Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathways. Br J Pharmacol. 1991 Feb;102(2):351–354. doi: 10.1111/j.1476-5381.1991.tb12177.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goldberg M. R., Robertson D. Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor. Pharmacol Rev. 1983 Sep;35(3):143–180. [PubMed] [Google Scholar]
  10. Guthrie S. K., Hariharan M., Grunhaus L. J. Yohimbine bioavailability in humans. Eur J Clin Pharmacol. 1990;39(4):409–411. doi: 10.1007/BF00315421. [DOI] [PubMed] [Google Scholar]
  11. Hedner T., Edgar B., Edvinsson L., Hedner J., Persson B., Pettersson A. Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers. Eur J Clin Pharmacol. 1992;43(6):651–656. doi: 10.1007/BF02284967. [DOI] [PubMed] [Google Scholar]
  12. Lacomblez L., Bensimon G., Isnard F., Diquet B., Lecrubier Y., Puech A. J. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. Clin Pharmacol Ther. 1989 Mar;45(3):241–251. doi: 10.1038/clpt.1989.24. [DOI] [PubMed] [Google Scholar]
  13. Le Verge R., Le Corre P., Chevanne F., Döe De Maindreville M., Royer D., Levy J. Determination of yohimbine and its two hydroxylated metabolites in humans by high-performance liquid chromatography and mass spectral analysis. J Chromatogr. 1992 Feb 14;574(2):283–292. doi: 10.1016/0378-4347(92)80041-n. [DOI] [PubMed] [Google Scholar]
  14. Montastruc P., Berlan M., Montastruc J. L. Effects of yohimbine on submaxillary salivation in dogs. Br J Pharmacol. 1989 Sep;98(1):101–104. doi: 10.1111/j.1476-5381.1989.tb16868.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Norris H. The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology. 1971 Mar;10(21):181–191. doi: 10.1016/0028-3908(71)90039-6. [DOI] [PubMed] [Google Scholar]
  16. Owen J. A., Nakatsu S. L., Condra M., Surridge D. H., Fenemore J., Morales A. Sub-nanogram analysis of yohimbine and related compounds by high-performance liquid chromatography. J Chromatogr. 1985 Aug 9;342(2):333–340. doi: 10.1016/s0378-4347(00)84524-7. [DOI] [PubMed] [Google Scholar]
  17. Owen J. A., Nakatsu S. L., Fenemore J., Condra M., Surridge D. H., Morales A. The pharmacokinetics of yohimbine in man. Eur J Clin Pharmacol. 1987;32(6):577–582. doi: 10.1007/BF02455991. [DOI] [PubMed] [Google Scholar]
  18. QUINTON R. M. THE INCREASE IN THE TOXICITY OF YOHIMBINE INDUCED BY IMIPRAMINE AND OTHER DRUGS IN MICE. Br J Pharmacol Chemother. 1963 Aug;21:51–66. doi: 10.1111/j.1476-5381.1963.tb01501.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rispail Y., Schmitt L., Berlan M., Montastruc J. L., Montastruc P. Yohimbine increases salivary secretion in depressed patients treated with tricyclic antidepressants. Eur J Clin Pharmacol. 1990;39(4):425–426. doi: 10.1007/BF00315426. [DOI] [PubMed] [Google Scholar]
  20. Senard J. M., Valet P., Durrieu G., Berlan M., Tran M. A., Montastruc J. L., Rascol A., Montastruc P. Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur J Clin Invest. 1990 Dec;20(6):613–619. doi: 10.1111/j.1365-2362.1990.tb01909.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES